| ID: | 156 | |
|---|---|---|
| Name: | Compound 156 | |
| Description: | Original numeration in publication: 5f | |
| Labels: | Training_set, Phthalazines | |
| CAS: | ||
| InChi Code: | InChI=1S/C30H23N3O2/c1-35-28-14-8-5-9-22(28)17-20-27(34)21-15-18-24(19-16-21)31-30-26-13-7-6-12-25(26)29(32-33-30)23-10-3-2-4-11-23/h2-20H,1H3,(H,31,33)/b20-17+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.36 |
Khedr, F.; Ibrahim, M.-K.; Eissa, I. H. a. A., H. S.; El-Adl, K. Phthalazine-based VEGFR-2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations. Arch. Pharm. (Weinheim) 2021, 354, e2100201. https://doi.org/10.1002/ardp.202100201 |
| 6.38708 |
Eq1: VEGFR-2 inhibition (Data used to train model) |